Investor Resources

Resources to Empower an Informed Investment

Explore financial reports, SEC filings, corporate presentations, and key governance materials—all in one place. Aprea Therapeutics is committed to transparency and accountability as we pursue transformative therapies for patients and long-term growth for shareholders.

FAQs

Show All

Aprea Therapeutics, Inc.
3805 Old Easton Road
Doylestown, PA 18902

Aprea Therapeutics, Inc. was incorporated in Delaware in May 2019. Our wholly-owned subsidiary, Aprea Therapeutics AB, was incorporated in Sweden in 2003.

You can view our Board of Directors by visiting the “Board of Directors” section of the “About” section of our website.

You can view our management team by visiting the “Management Team” section of the “About” section of our website.

December 31

EisnerAmper LLP

Aprea Therapeutics is traded on The NASDAQ Stock Market LLC under the symbol “APRE”.

Aprea Therapeutics went public on October 3, 2019.

Shares can be purchased through a stockbroker of your choice.

Currently, Aprea Therapeutics does not offer a dividend or a dividend reinvestment program.

Aprea Therapeutics’ transfer agent is Computershare Trust Company, N.A. You can contact Computershare Trust Company at:
Computershare
PO Box 505000
Louisville, KY 40233-5000

If you have misplaced your stock certificates, please contact our transfer agent, Computershare. There may be a fee involved for replacing lost stock certificates.

You must send both your old and new addresses to our transfer agent, Computershare, PO Box 505000, Louisville, KY 40233-5000, by U.S. mail. Each stockholder in question must sign a request for an address change.

Quarterly and Annual Reports and other investor materials, when available, can be found in the “SEC Filings” section of the “Investors” section of our website. Additionally, all SEC filings can be accessed directly from the SEC at www.sec.gov.

You can view our recent press releases by visiting the “News & Events” section of the “Investors” section of our website.

For media inquiries please send an email to info@aprea.com.

You can view information on our development programs by visiting the “Pipeline” section of our website.

For investor related questions please visit the “Investor Contact” section of the “Investor Resources” section of our website and fill out our Investor Contact web form. Alternatively, you can send an email to info@aprea.com.

Please visit the “Email Alerts” section of the “Investor Resources” of our website and fill out our web form to be added to our distribution list.

Please visit the “Investor Contact” section of the “Investor Resources” section of our website and fill out our Investor Contact web form. Alternatively, you can send an email to info@aprea.com.

What Matters Most is a Cure